Vancity Investment Management Ltd Sells 4,437 Shares of Danaher Corporation $DHR

Vancity Investment Management Ltd lessened its holdings in Danaher Corporation (NYSE:DHRFree Report) by 4.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 102,773 shares of the conglomerate’s stock after selling 4,437 shares during the quarter. Danaher comprises 3.2% of Vancity Investment Management Ltd’s investment portfolio, making the stock its 12th biggest position. Vancity Investment Management Ltd’s holdings in Danaher were worth $23,526,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the business. Norges Bank bought a new position in Danaher in the 4th quarter worth about $2,177,106,000. Viking Global Investors LP boosted its position in shares of Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock valued at $574,351,000 after acquiring an additional 2,455,994 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Danaher by 104.7% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock valued at $991,923,000 after acquiring an additional 2,216,789 shares during the last quarter. Generation Investment Management LLP grew its holdings in shares of Danaher by 34.0% during the third quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after purchasing an additional 1,689,020 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in shares of Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $177.74 on Friday. The business has a 50 day moving average of $179.99 and a 200 day moving average of $203.25. The company has a market capitalization of $125.80 billion, a price-to-earnings ratio of 34.38, a PEG ratio of 2.27 and a beta of 0.81. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.

Danaher (NYSE:DHRGet Free Report) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. The business had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.88 earnings per share. On average, sell-side analysts predict that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on DHR shares. Guggenheim lowered their target price on shares of Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. cut their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. UBS Group decreased their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Evercore raised their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. Finally, Argus dropped their price objective on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $233.61.

Read Our Latest Stock Analysis on Danaher

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.